PharmiWeb.com - Global Pharma News & Resources

Pharmaco - Press Releases

Date Title Company
04-Nov-2024 Pentixapharm Welcomes CMS Decision to Enhance Reimbursement for Diagnostic Radiopharmaceuticals Pentixapharm Holding AG
04-Nov-2024 Experts call for global action on photodisinfection technology that could prevent thousands of AMR-related deaths The International Photodynamic Association (IPA)
04-Nov-2024 MEDICLIN increases consolidated sales and operating result - Management Board confirms annual forecast for 2024 MEDICLIN AG
04-Nov-2024 CureVac Strengthens Leadership Team with Appointment of Seasoned Industry Executive Axel Sven Malkomes as Chief Financial Officer CureVac
04-Nov-2024 CureVac to Present at the 12th International mRNA Health Conference CureVac
04-Nov-2024 Original-Research: CS MEDICA A/S (von NuWays AG) CS MEDICA A/S
04-Nov-2024 Relief Therapeutics Signs Non-Binding Letter of Intent with Renexxion for Reverse Merger Relief Therapeutics Holding SA
04-Nov-2024 Formycon applies for admission to the Prime Standard of the Frankfurt Stock Exchange Formycon AG
01-Nov-2024 Nxera Pharma Operational Highlights and Consolidated Results for the Third Quarter and First Nine Months of 2024 Nxera Pharma Co., Ltd
01-Nov-2024 Ulrika Ringdahl new CEO of SmiLe Venture Hub SmiLe Venture Hub
01-Nov-2024 Primary Trauma Care Foundation launches new ‘Life + Limb’ brand to engage broader audience Primary Trauma Care Foundation (PTCF)
01-Nov-2024 Domino Makes It Easier Than Ever for Pharmaceutical Manufacturers to Explore Individual Dose Serialisation Domino Printing Sciences
01-Nov-2024 Mentice has received a €1,062,750 EUR order for simulation solutions from a top 20 global MedTech company Mentice
01-Nov-2024 Nonacus introduces its first ultrasensitive qPCR assay for ESR1 mutation detection Nonacus Ltd
01-Nov-2024 ABPI welcomes the Chancellor’s backing of life sciences in the Budget ABPI
01-Nov-2024 OKYO Pharma to Present at International Tear Film and Ocular Surface Society Conference OKYO Pharma
01-Nov-2024 The Nomination Committee has been appointed for the Aqilion Annual General Meeting 2025 Aqilion AB
31-Oct-2024 BRAIN Biotech AG and Akribion Therapeutics GmbH sign exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology BRAIN Biotech AG
31-Oct-2024 BRAIN Biotech AG signs exclusive pharma licensing agreement for G-dase E® CRISPR-Cas technology with Akribion Therapeutics GmbH for up to EUR 92.3 million milestone fees plus royalties BRAIN Biotech AG
31-Oct-2024 Secarna Announces Appointment of Konstantin Petropoulos as Chief Executive Office Secarna Pharmaceuticals GmbH & Co. KG